相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IXIARO((R)) updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis
Tomas Jelinek
EXPERT REVIEW OF VACCINES (2013)
Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study
Elina O. Erra et al.
VACCINE (2013)
Vaccinating against Japanese encephalitis virus: what have we learned from recent clinical trials?
Katrin Dubischar-Kastner et al.
EXPERT REVIEW OF VACCINES (2012)
Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
Tabitha Woolpert et al.
VACCINE (2012)
Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children
Kenji Okada et al.
VACCINE (2012)
Estimated global incidence of Japanese encephalitis: a systematic review
Grant L. Campbell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2011)
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51
Susanne Eder et al.
VACCINE (2011)
Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®
Elisabeth Schuller et al.
VACCINE (2011)
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers
Yvonne Van Gessel et al.
VACCINE (2011)
Introduction of Japanese Encephalitis Virus Genotype I, India
Pradip V. Fulmali et al.
EMERGING INFECTIOUS DISEASES (2011)
Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973-2008
Susan L. Hills et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up
Katrin Dubischar-Kastner et al.
VACCINE (2010)
Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
Katrin Dubischar-Kastner et al.
VACCINE (2010)
Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
A. Kaltenboeck et al.
VACCINE (2010)
Functional Modulation of Dendritic Cells and Macrophages by Japanese Encephalitis Virus through MyD88 Adaptor Molecule-Dependent and -Independent Pathways
Abi G. Aleyas et al.
JOURNAL OF IMMUNOLOGY (2009)
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
Elisabeth Schuller et al.
VACCINE (2009)
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
A. Kaltenboeck et al.
VACCINE (2009)
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine
E. Tauber et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
E. Schuller et al.
VACCINE (2008)
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
Elisabeth Schuller et al.
VACCINE (2008)
Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
E. Tauber et al.
LANCET (2007)
Anaphylaxis:: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Jens U. Rueggeberg et al.
VACCINE (2007)
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
Arthur Lyons et al.
VACCINE (2007)
Japanese encephalitis outbreak, India, 2005
Manmohan Parida et al.
EMERGING INFECTIOUS DISEASES (2006)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study
H Ohrr et al.
LANCET (2005)
Effect of irrigated rice agriculture on Japanese encephalitis, including challenges and opportunities for integrated vector management
J Keiser et al.
ACTA TROPICA (2005)
Arguments for live flavivirus vaccines
J Hombach et al.
LANCET (2004)
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
JS Mackenzie et al.
NATURE MEDICINE (2004)
Japanese encephalitis in a Swedish tourist after travelling to Java and Bali
MR Östlund et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Live flavivirus vaccines: reasons for caution
SJ Seligman et al.
LANCET (2004)
Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine
S Kuzuhara et al.
VACCINE (2003)
Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997
JC Lloyd et al.
VACCINE (2003)
Origin and evolution of Japanese encephalitis virus in southeast Asia
T Solomon et al.
JOURNAL OF VIROLOGY (2003)
Japanese encephalitis vaccine for travelers: Exploring the limits of risk
DR Shlim et al.
CLINICAL INFECTIOUS DISEASES (2002)
Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study
MB Bista et al.
LANCET (2001)
A purified inactivated Japanese encephalitis virus vaccine made in vero cells
AK Srivastava et al.
VACCINE (2001)
分享论文
